Firm involving high tech, life sciences and biotech
Austrianova is one firm that does things that contains high tech, life sciences and biotech. It is accompanied with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based company that specialises in the enclosure of living cells or bacteria in tiny tablets for protection which is also identified as cell encapsulation technology, isolation, storage and transportation. We were first created in the year 2007 and was based in Singapore's top research biotech hub, Biopolis that has large-scale vision in supporting encapsulation facilities like micro encapsulation.
There is a fast increasing matter of liking in healthy repair and more precise, in the topic of neutraceuticals which is the knowing and use of probiotic bacteria. Thus, probiotics encapsulation was developed. The cell-in-a-box technology was created by Austranova with the aim to protect, separate, contain and deliver living cells. This great technology can be used for various purposes and can be put to probiotics, cosmetics and agriculture environmental protection and screening as well as developing the foundation of a authoritative study instrument.
In healthcare, this skill helps run protected embedding of cells or stem cells such as cell therapy, holding them alone from the immune system and giving long period production of therapeutic molecules in patients. In biotechnology, the cell-in-a-box skill defends cells in bioreactors and fermentors and at the same time, it shorten cleansing of bioproducts formed from the cells and it cut down making price too.
A huge gauge cGMP facility for the production of biomedical grade encapsulated cell items was beforehand positively created and right now, Austrianova is in the process of making this experience in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to permit inferior amounts of chemotherapy to be used more efficaciously without the casual debilitating side results. The encapsulated cell are sited, using supraselective catheterisation, into blood vessels that leads to the tumor where they locally alter a chemotherapeutic product to its tumor toxic product.
Visit our site for more details: Cell Encapsulation Technology, Probiotics Encapsulation, GMP Manufacturing.
